About EpiBone
EpiBone is a private company based in New York, New York. It has reported $47,818,753 raised in four offerings on Form D since February 2020. Its chief executive is Nina Tandon.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2025 | Oct 24, 2025 | $4,287,429of $4.3M target | 131 | $32,728 | EquityRule 506(b) | Form D ↗ |
| Dec 12, 2022 | Dec 27, 2022 | $18,453,016of $36.7M target | 51 | $361K | EquityRule 506(b) | Form D ↗ |
| Feb 3, 2021 | Feb 12, 2021 | $750,000of $5.0M target | 4 | $187K | DebtRule 506(b) | Form D ↗ |
| Jan 23, 2020 | Feb 6, 2020 | $24,328,308of $26.5M target | 140 | $173K | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, four offerings | $47,818,753 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on EpiBone's Form D filed Oct 24, 2025.
RL
Robert Langer
Director
GN
Gordana Vunjak-Novakovic
Director
NT
Nina Tandon
Chief Executive Officer and director
SB
Sarindr Bhumiratana
Executive officer and director
DZ
David Zhu
Director
Earlier filings also listed Elma Hawkins (director, last listed Dec 2022).